108 related articles for article (PubMed ID: 11778005)
1. Prevention of relapse in schizophrenia.
Geddes J
N Engl J Med; 2002 Jan; 346(1):56-8. PubMed ID: 11778005
[No Abstract] [Full Text] [Related]
2. Prevention of relapse in schizophrenia.
Lieberman J; Stroup S; Schneider L
N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11987324
[No Abstract] [Full Text] [Related]
3. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
Csernansky JG; Mahmoud R; Brenner R;
N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
[TBL] [Abstract][Full Text] [Related]
4. Prevention of relapse in schizophrenia.
Curtin F
N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11986420
[No Abstract] [Full Text] [Related]
5. Schizophrenia.
Lawrie S; McIntosh A; Nadeem Z
Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
[No Abstract] [Full Text] [Related]
6. Prevention of relapse in schizophrenia.
Stalman SL
N Engl J Med; 2002 May; 346(18):1412-3; author reply 1412-3. PubMed ID: 11987323
[No Abstract] [Full Text] [Related]
7. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
Yoshida K; Higuchi H; Hishikawa Y
Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
[TBL] [Abstract][Full Text] [Related]
8. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
9. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
[TBL] [Abstract][Full Text] [Related]
10. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
[No Abstract] [Full Text] [Related]
11. An importance of dose in antipsychotic combination therapy for schizophrenia.
Suzuki T
J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
[No Abstract] [Full Text] [Related]
12. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
Dittert S; Soyka M; Winter C; Möller HJ
Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
[No Abstract] [Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
14. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
Pajonk FG
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
[TBL] [Abstract][Full Text] [Related]
15. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
16. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
17. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
Meibach RC
Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283
[No Abstract] [Full Text] [Related]
18. [From neuroleptics to antipsychotics: the cognitive and emotional impact].
Blin O; Fakra E; Tardieu S; Micallef J
Encephale; 2002; 28 Spec No 2 Pt 2():S16-8. PubMed ID: 12587350
[No Abstract] [Full Text] [Related]
19. Relapse in patients with schizophrenia: a comparison between risperidone and haloperidol.
de Sena EP; Santos-Jesus R; Miranda-Scippa A; Quarantini Lde C; Oliveira IR
Braz J Psychiatry; 2003 Oct; 25(4):220-3. PubMed ID: 15328547
[TBL] [Abstract][Full Text] [Related]
20. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
